TMC Life Sciences suspends GCEO; appoints temporary replacement

TMC Life Sciences Bhd group CEO Dr Melvin Heng Jun Li

PETALING JAYA: TMC Life Sciences Bhd has appointed director Dr Melvin Heng Jun Li as its group chief executive officer (GCEO) with immediate effect, following the suspension of Wan Nadiah Wan Mohd Abdullah Yaakob.

In a filing with Bursa Malaysia, the company said Wan Nadiah was also suspended as CEO of Thomson Hospitals Sdn Bhd, resulting in the powers, authorities and functions vested in her as the GCEO and CEO to be suspended with effect from Jan 29, 2024 until further announcement by the board.

The company added that it will continue its business as usual, while Heng, temporarily assumes the duties and functions of its GCEO.